{"transactions":[{"id":4638822,"issuer":{"id":7895,"kind":"organization","name":"Arrive AI Inc.","symbol":"ARAI"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2026-10-09T21:20:29.000Z","date":"2026-10-02","kind":"grant","planned":false,"acquired":true,"shares":172811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (RSUs) were granted on October 2, 2026, which vest on September 30, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs do not expire, they either vest or are canceled prior to the vesting date."}],"balance_after":172811,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":172811},"source":{"system":"sec-edgar","filing":"0001493152-26-046605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818274/000149315226046605/ownership.xml","form_type":"4"}},{"id":713687,"issuer":{"id":7895,"kind":"organization","name":"Arrive AI Inc.","symbol":"ARAI"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2026-07-07T20:23:06.000Z","date":"2026-07-06","kind":"grant","planned":false,"acquired":true,"shares":87413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (RSUs) were granted on July 6, 2026, which vest on June 30, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs do not expire, they either vest or are canceled prior to vesting date."}],"balance_after":87413,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":87413},"source":{"system":"sec-edgar","filing":"0001493152-26-032334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818274/000149315226032334/ownership.xml","form_type":"4"}},{"id":309649,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2026-05-15T21:25:17.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":1447.5039,"price":97.15,"value":140625.003885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person."}],"balance_after":1447.5039,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1447.5039},"source":{"system":"sec-edgar","filing":"0000064803-26-000080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000080/form4.xml","form_type":"4"}},{"id":819774,"issuer":{"id":7895,"kind":"organization","name":"Arrive AI Inc.","symbol":"ARAI"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2026-04-02T20:05:17.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":47052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (RSUs) were granted on March 31, 2026, which vest on March 31, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs do not expire, they either vest or are canceled prior to vesting date."}],"balance_after":47052,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":47052},"source":{"system":"sec-edgar","filing":"0001493152-26-014906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818274/000149315226014906/ownership.xml","form_type":"4"}},{"id":311334,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-20T21:05:17.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":582,"price":71.86,"value":41822.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of common stock issued in payment of a pro rata semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan."}],"balance_after":582,"source":{"system":"sec-edgar","filing":"0000064803-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000022/form4.xml","form_type":"4"}},{"id":951806,"issuer":{"id":7895,"kind":"organization","name":"Arrive AI Inc.","symbol":"ARAI"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2026-01-05T22:15:21.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":14259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (RSUs) were granted on December 31, 2025, which vest on December 30, 2026. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs do not expire, they either vest or are canceled prior to vesting date."}],"balance_after":21551,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":14259},"source":{"system":"sec-edgar","filing":"0001493152-26-000431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818274/000149315226000431/ownership.xml","form_type":"4"}},{"id":1015863,"issuer":{"id":7895,"kind":"organization","name":"Arrive AI Inc.","symbol":"ARAI"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2025-10-20T20:48:38.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":7292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (RSUs) were granted on October 6, 2025, which vest on September 30, 2026. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs do not expire, they either vest or are canceled prior to vesting date."}],"balance_after":7292,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7292},"source":{"system":"sec-edgar","filing":"0001493152-25-018657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818274/000149315225018657/ownership.xml","form_type":"4/A","original_submission_date":"2025-10-08"}},{"id":1021580,"issuer":{"id":7895,"kind":"organization","name":"Arrive AI Inc.","symbol":"ARAI"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T20:21:57.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":7292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person for his service to the Issuer's board of directors in 2025, in return for $0.00 in consideration."}],"balance_after":18202,"source":{"system":"sec-edgar","filing":"0001493152-25-017430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818274/000149315225017430/ownership.xml","form_type":"4"}},{"id":1049895,"issuer":{"id":7895,"kind":"organization","name":"Arrive AI Inc.","symbol":"ARAI"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T00:44:31.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person for his service to the Issuer's board of directors in 2025, in return for $0.00 in consideration."}],"balance_after":10910,"source":{"system":"sec-edgar","filing":"0001641172-25-026490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818274/000164117225026490/ownership.xml","form_type":"4"}},{"id":1049894,"issuer":{"id":7895,"kind":"organization","name":"Arrive AI Inc.","symbol":"ARAI"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T00:44:31.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":7693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person for his service to the Issuer's board of directors in 2025, in return for $0.00 in consideration."}],"balance_after":10054,"source":{"system":"sec-edgar","filing":"0001641172-25-026490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818274/000164117225026490/ownership.xml","form_type":"4"}},{"id":1975019,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-03T21:15:27.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":11782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date."}],"balance_after":11782,"derivative":{"exercise_price":469.03,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":11782},"source":{"system":"sec-edgar","filing":"0001156039-23-000025","document":"wf-form4_167787809281315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000025/wf-form4_167787809281315.xml","form_type":"4"}},{"id":1975018,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T21:15:27.000Z","date":"2023-03-02","kind":"tax_withholding","acquired":false,"shares":4650,"price":468.78,"value":2179827.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":63725,"source":{"system":"sec-edgar","filing":"0001156039-23-000025","document":"wf-form4_167787809281315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000025/wf-form4_167787809281315.xml","form_type":"4"}},{"id":1975017,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T21:15:27.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":9716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/2/2023."}],"balance_after":68375,"source":{"system":"sec-edgar","filing":"0001156039-23-000025","document":"wf-form4_167787809281315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000025/wf-form4_167787809281315.xml","form_type":"4"}},{"id":1975016,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T21:15:27.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":3065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026."}],"balance_after":58659,"source":{"system":"sec-edgar","filing":"0001156039-23-000025","document":"wf-form4_167787809281315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000025/wf-form4_167787809281315.xml","form_type":"4"}},{"id":1975015,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T21:15:27.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":587,"price":469.03,"value":275320.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":55594,"source":{"system":"sec-edgar","filing":"0001156039-23-000025","document":"wf-form4_167787809281315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000025/wf-form4_167787809281315.xml","form_type":"4"}},{"id":2355649,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-03T21:45:38.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":11594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 11,594 shares, and is exercisable in three annual installments, with one installment of 3,864 shares and two installments of 3,865 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date."}],"balance_after":11594,"derivative":{"exercise_price":451.5,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":11594},"source":{"system":"sec-edgar","filing":"0001156039-22-000024","document":"wf-form4_164634390386028.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000024/wf-form4_164634390386028.xml","form_type":"4"}},{"id":2355648,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:45:38.000Z","date":"2022-03-02","kind":"gift","acquired":false,"shares":1420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56181,"source":{"system":"sec-edgar","filing":"0001156039-22-000024","document":"wf-form4_164634390386028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000024/wf-form4_164634390386028.xml","form_type":"4"}},{"id":2355647,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:45:38.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":413,"price":463.49,"value":191421.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":57601,"source":{"system":"sec-edgar","filing":"0001156039-22-000024","document":"wf-form4_164634390386028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000024/wf-form4_164634390386028.xml","form_type":"4"}},{"id":2355646,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:45:38.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/2022."}],"balance_after":58014,"source":{"system":"sec-edgar","filing":"0001156039-22-000024","document":"wf-form4_164634390386028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000024/wf-form4_164634390386028.xml","form_type":"4"}},{"id":2355645,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:45:38.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":2907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 969 shares each on 3/1/2023, 3/1/2024 and 3/1/2025."}],"balance_after":49764,"source":{"system":"sec-edgar","filing":"0001156039-22-000024","document":"wf-form4_164634390386028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000024/wf-form4_164634390386028.xml","form_type":"4"}},{"id":2355644,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:45:38.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":4162,"price":451.5,"value":1879143.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":46857,"source":{"system":"sec-edgar","filing":"0001156039-22-000024","document":"wf-form4_164634390386028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000024/wf-form4_164634390386028.xml","form_type":"4"}},{"id":2695655,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":14761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option represents a right to purchase a total of 14,761 shares and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares beginning on September 1, 2018, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":232.04,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":14761},"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695654,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":19908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on September 1, 2017, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":166.97,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":19908},"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695653,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":4038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option represents a right to purchase a total of 8,074 shares and is exercisable in six semi-annual installments, with two installments of 1,345 shares each and four installments of 1,346 shares each beginning on December 1, 2016, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":132.51,"expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":4038},"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695652,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":1962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option represents a right to purchase a total of 5,883 shares and is exercisable in six semi-annual installments, with three installments of 980 shares each and three installments of 981 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":131.8,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":1962},"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695651,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":5775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option represents a right to purchase a total of 5,775 shares and is exercisable in six semi-annual installments, with three installments of 962 shares each and three installments of 963 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":146.93,"expiration_date":"2025-03-02","underlying":"Common Stock","underlying_shares":5775},"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695650,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-25","kind":"gift","acquired":false,"shares":3301,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51019,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695649,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":4100,"price":397.91,"value":1631431.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $397.50 to $398.39. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":54320,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695648,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":1100,"price":396.5,"value":436150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $396.23 to $396.56. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":58420,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695647,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":15262,"price":395.67,"value":6038715.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $395.23 to $396.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":59520,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695646,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":8163,"price":394.62,"value":3221283.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $394.18 to $395.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":74782,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695645,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":17819,"price":393.56,"value":7012845.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $393.17 to $394.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":82945,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695644,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":14761,"price":232.04,"value":3425142.44,"ownership":{"direct":true},"balance_after":100764,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695643,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":19908,"price":166.97,"value":3324038.76,"ownership":{"direct":true},"balance_after":86003,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695642,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":4038,"price":132.51,"value":535075.38,"ownership":{"direct":true},"balance_after":66095,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695641,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":1962,"price":131.8,"value":258591.6,"ownership":{"direct":true},"balance_after":62057,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2695640,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T20:31:05.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":5775,"price":146.93,"value":848520.75,"ownership":{"direct":true},"balance_after":60095,"source":{"system":"sec-edgar","filing":"0001156039-21-000050","document":"wf-form4_162206103641936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000050/wf-form4_162206103641936.xml","form_type":"4"}},{"id":2814817,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-03T21:35:24.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":12357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 12,357 shares, and is exercisable in three annual installments of 4,119 shares each,  beginning on 3/1/2022, which is the one-year anniversary of the option grant date."}],"balance_after":12357,"derivative":{"exercise_price":311.48,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":12357},"source":{"system":"sec-edgar","filing":"0001156039-21-000030","document":"wf-form4_161480728684695.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000030/wf-form4_161480728684695.xml","form_type":"4"}},{"id":2814816,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:35:24.000Z","date":"2021-03-02","kind":"tax_withholding","acquired":false,"shares":483,"price":311.66,"value":150531.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":54320,"source":{"system":"sec-edgar","filing":"0001156039-21-000030","document":"wf-form4_161480728684695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000030/wf-form4_161480728684695.xml","form_type":"4"}},{"id":2814815,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:35:24.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":23222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/2021."}],"balance_after":54803,"source":{"system":"sec-edgar","filing":"0001156039-21-000030","document":"wf-form4_161480728684695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000030/wf-form4_161480728684695.xml","form_type":"4"}},{"id":2814814,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:35:24.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":3010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,003 shares each on 3/1/2022 and 3/1/2023, and 1,004 on 3/1/2024."}],"balance_after":31581,"source":{"system":"sec-edgar","filing":"0001156039-21-000030","document":"wf-form4_161480728684695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000030/wf-form4_161480728684695.xml","form_type":"4"}},{"id":2814813,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:35:24.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":10633,"price":311.48,"value":3311966.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":28571,"source":{"system":"sec-edgar","filing":"0001156039-21-000030","document":"wf-form4_161480728684695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000030/wf-form4_161480728684695.xml","form_type":"4"}},{"id":2950341,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-10T21:32:05.000Z","date":"2020-12-08","kind":"gift","acquired":false,"shares":2589,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39204,"source":{"system":"sec-edgar","filing":"0001156039-20-000103","document":"wf-form4_160763591286113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000103/wf-form4_160763591286113.xml","form_type":"4"}},{"id":3228114,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-04T21:44:01.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":15926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 15,926 shares, and is exercisable in three annual installments, with one installment of 5,308 shares and two installments of 5,309 shares each, beginning on 3/2/2021, which is the one-year anniversary of the option grant date."}],"balance_after":15926,"derivative":{"exercise_price":271.27,"expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":15926},"source":{"system":"sec-edgar","filing":"0001127602-20-009441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009441/form4.xml","form_type":"4"}},{"id":3228113,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T21:44:01.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":37420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/2/2020."}],"balance_after":41793,"source":{"system":"sec-edgar","filing":"0001127602-20-009441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009441/form4.xml","form_type":"4"}},{"id":3228112,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T21:44:01.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":2996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 998 shares on 3/2/2021, and 999 shares each on 3/2/2022 and 3/2/2023."}],"balance_after":4373,"source":{"system":"sec-edgar","filing":"0001127602-20-009441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009441/form4.xml","form_type":"4"}},{"id":3228111,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T21:44:01.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":17374,"price":271.27,"value":4713044.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":1377,"source":{"system":"sec-edgar","filing":"0001127602-20-009441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009441/form4.xml","form_type":"4"}},{"id":3502722,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-04T20:44:19.000Z","date":"2019-06-03","kind":"tax_withholding","acquired":false,"shares":2033,"price":276.44,"value":562002.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":18751,"source":{"system":"sec-edgar","filing":"0001127602-19-020730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219020730/form4.xml","form_type":"4"}},{"id":3502721,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-04T20:44:19.000Z","date":"2019-03-20","kind":"gift","acquired":false,"shares":2272,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20784,"source":{"system":"sec-edgar","filing":"0001127602-19-020730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219020730/form4.xml","form_type":"4"}},{"id":3613904,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-05T21:08:17.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":12187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option represents a right to purchase a total of 12,187 shares, and is exercisable in three annual installments, with two installments of 4,062 shares each and one installment of 4,063 shares, beginning on 3/1/2020, which is the one-year anniversary of the option grant date."}],"balance_after":12187,"derivative":{"exercise_price":307.68,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":12187},"source":{"system":"sec-edgar","filing":"0001127602-19-009899","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219009899/form4.xml","form_type":"4"}},{"id":3613903,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-05T21:08:17.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":4033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents performance based restricted share units. Restrictions lapse on 6/1/19."}],"balance_after":23056,"source":{"system":"sec-edgar","filing":"0001127602-19-009899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219009899/form4.xml","form_type":"4"}},{"id":3613902,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-05T21:08:17.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":2641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted share units. Restrictions lapse as follows: 880 shares each on 3/1/2020 and 3/1/2021, and 881 on 3/1/2022."}],"balance_after":19023,"source":{"system":"sec-edgar","filing":"0001127602-19-009899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219009899/form4.xml","form_type":"4"}},{"id":3613901,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-05T21:08:17.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":2940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/19."}],"balance_after":16382,"source":{"system":"sec-edgar","filing":"0001127602-19-009899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219009899/form4.xml","form_type":"4"}},{"id":3613900,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-05T21:08:17.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":2217,"price":307.68,"value":682126.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":13442,"source":{"system":"sec-edgar","filing":"0001127602-19-009899","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219009899/form4.xml","form_type":"4"}},{"id":3905814,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-05T20:22:53.000Z","date":"2018-06-01","kind":"tax_withholding","acquired":false,"shares":275,"price":221.5,"value":60912.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":15659,"source":{"system":"sec-edgar","filing":"0001127602-18-020019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218020019/form4.xml","form_type":"4"}},{"id":4008599,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":4036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option represents a right to purchase a total of 8,074 shares, is exercisable in two installments of 1,345 shares each and four installments of 1,346 shares each, beginning on December 1, 2016, which is the six-month anniversary of the option grant date."}],"balance_after":4038,"derivative":{"exercise_price":132.51,"expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":4036},"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008598,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":6466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, representing a right to purchase a total of 9,698 shares, is exercisable in four semi-annual installments of 1,616 shares each and two semi-annual installments of 1,617 shares each beginning on September 3, 2014, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":89.44,"expiration_date":"2021-03-03","underlying":"Common Stock","underlying_shares":6466},"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008597,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":3921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, representing a right to purchase a total of 5,883 shares, is exercisable in three semi-annual installments of 980 shares each and three semi-annual installments of 981 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":1962,"derivative":{"exercise_price":131.8,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":3921},"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008596,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":3948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing a right to purchase a total of 11,843 shares, is exercisable in one installment of 1,973 shares and five semi-annual installments of 1,974 shares each beginning on September 1, 2013, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":61.88,"expiration_date":"2020-03-01","underlying":"Common Stock","underlying_shares":3948},"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008595,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":4100,"price":231.29,"value":948289.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $231.01 to $231.83. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15934,"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008594,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":5372,"price":230.44,"value":1237923.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $230.00 to $230.97. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20034,"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008593,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":15104,"price":229.19,"value":3461685.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $229.00 to $229.98. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25406,"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008592,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":4036,"price":132.51,"value":534810.36,"ownership":{"direct":true},"balance_after":40510,"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008591,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":6466,"price":89.44,"value":578319.04,"ownership":{"direct":true},"balance_after":36474,"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008590,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":3921,"price":131.8,"value":516787.8,"ownership":{"direct":true},"balance_after":30008,"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008589,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":3948,"price":61.88,"value":244302.24,"ownership":{"direct":true},"balance_after":26087,"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4008588,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:35:49.000Z","date":"2018-03-05","kind":"gift","acquired":false,"shares":2448,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22139,"source":{"system":"sec-edgar","filing":"0001127602-18-010570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010570/form4.xml","form_type":"4"}},{"id":4016022,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-05T21:43:05.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":14761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 14,761 shares, and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares, beginning on September 1, 2018, which is the six-month anniversary of the option grant date."}],"balance_after":14761,"derivative":{"exercise_price":232.04,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":14761},"source":{"system":"sec-edgar","filing":"0001127602-18-010095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010095/form4.xml","form_type":"4"}},{"id":4016021,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:43:05.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":4211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/18."}],"balance_after":24587,"source":{"system":"sec-edgar","filing":"0001127602-18-010095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010095/form4.xml","form_type":"4"}},{"id":4016020,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:43:05.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":1688,"price":233.08,"value":393439.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":20376,"source":{"system":"sec-edgar","filing":"0001127602-18-010095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010095/form4.xml","form_type":"4"}},{"id":4016019,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:43:05.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":3502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,167 shares each on 3/1/2019 and 3/1/2020, and 1,168 on 3/1/2021."}],"balance_after":22064,"source":{"system":"sec-edgar","filing":"0001127602-18-010095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010095/form4.xml","form_type":"4"}},{"id":4016018,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:43:05.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":660,"price":232.04,"value":153146.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":18562,"source":{"system":"sec-edgar","filing":"0001127602-18-010095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760218010095/form4.xml","form_type":"4"}},{"id":4296092,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-02T20:03:11.000Z","date":"2017-06-01","kind":"tax_withholding","acquired":false,"shares":291,"price":187.69,"value":54617.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":19222,"source":{"system":"sec-edgar","filing":"0001127602-17-020299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217020299/form4.xml","form_type":"4"}},{"id":4296091,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-02T20:03:11.000Z","date":"2017-05-08","kind":"gift","acquired":false,"shares":3211,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19513,"source":{"system":"sec-edgar","filing":"0001127602-17-020299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217020299/form4.xml","form_type":"4"}},{"id":4397777,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-07T21:17:57.000Z","date":"2017-03-03","kind":"tax_withholding","acquired":false,"shares":977,"price":166,"value":162182.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":22724,"source":{"system":"sec-edgar","filing":"0001127602-17-010578","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010578/form4.xml","form_type":"4"}},{"id":4404850,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-03T21:18:11.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":19908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date."}],"balance_after":19908,"derivative":{"exercise_price":166.97,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":19908},"source":{"system":"sec-edgar","filing":"0001127602-17-010143","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010143/form4.xml","form_type":"4"}},{"id":4404849,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T21:18:11.000Z","date":"2017-03-02","kind":"tax_withholding","acquired":false,"shares":129,"price":165.97,"value":21410.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":23701,"source":{"system":"sec-edgar","filing":"0001127602-17-010143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010143/form4.xml","form_type":"4"}},{"id":4404848,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T21:18:11.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":4867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,622 shares each on 3/1/2018 and 3/1/2019, and 1,623 on 3/1/2020."}],"balance_after":23830,"source":{"system":"sec-edgar","filing":"0001127602-17-010143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010143/form4.xml","form_type":"4"}},{"id":4404847,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":14654,"kind":"person","name":"Gallina John E","position":1,"cik":"0001433032","reported_name":"Gallina John E","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-03T21:18:11.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":165,"price":166.97,"value":27550.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":18963,"source":{"system":"sec-edgar","filing":"0001127602-17-010143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760217010143/form4.xml","form_type":"4"}}]}